PHARMAESSENTIA Trademark

Trademark Overview

On Wednesday, April 9, 2025, a trademark application was filed for PHARMAESSENTIA with the United States Patent and Trademark Office. The USPTO has given the PHARMAESSENTIA trademark a serial number of 99129029. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, October 14, 2025. This trademark is owned by PHARMAESSENTIA CORPORATION. The PHARMAESSENTIA trademark is filed in the Paper & Printed Material Products category with the following description:

Printed matter, namely, instruction booklet for use of pharmaceutical preparation in the field of cancer treatment; printed newsletters in the field of field of cancer treatment; printed books in the field of cancer treatment and printed posters; printed magazine, journals, or books in the field of field of cancer treatment; Printed publications; printed manuals in the field of instruction booklet for use of pharmaceutical preparation in the field of cancer treatment, namely, in the field of myeloproliferative neoplasms (MPNs); printed periodicals in the field of cancer treatment, namely, in the field of myeloproliferative neoplasms (MPNs) ;printed leaflets about cancer treatment, namely, in the field of myeloproliferative neoplasms (MPNs); printed pamphlets in the field of cancer treatment, namely, in the field of myeloproliferative neoplasms (MPNs).
pharmaessentia

General Information

Serial Number99129029
Word MarkPHARMAESSENTIA
Filing DateWednesday, April 9, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPrinted matter, namely, instruction booklet for use of pharmaceutical preparation in the field of cancer treatment; printed newsletters in the field of field of cancer treatment; printed books in the field of cancer treatment and printed posters; printed magazine, journals, or books in the field of field of cancer treatment; Printed publications; printed manuals in the field of instruction booklet for use of pharmaceutical preparation in the field of cancer treatment, namely, in the field of myeloproliferative neoplasms (MPNs); printed periodicals in the field of cancer treatment, namely, in the field of myeloproliferative neoplasms (MPNs) ;printed leaflets about cancer treatment, namely, in the field of myeloproliferative neoplasms (MPNs); printed pamphlets in the field of cancer treatment, namely, in the field of myeloproliferative neoplasms (MPNs).

Classification Information

International Class016 - Paper, cardboard and goods made from these materials, not included in other classes; printed matter; bookbinding material; photographs; stationery; adhesives for stationery or household purposes; artists' materials; paint brushes; typewriters and office requisites (except furniture); instructional and teaching material (except apparatus); plastic materials for packaging (not included in other classes); printers' type; printing blocks.
US Class Codes002, 005, 022, 023, 029, 037, 038, 050
Class Status Code6 - Active
Class Status DateWednesday, April 9, 2025
Primary Code016
First Use Anywhere DateTuesday, November 16, 2021
First Use In Commerce DateTuesday, November 16, 2021

Trademark Owner History

Party NamePHARMAESSENTIA CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTaipei City 115 115603
TW

Trademark Events

Event DateEvent Description
Friday, July 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 5, 2025ASSIGNED TO EXAMINER
Wednesday, April 9, 2025NEW APPLICATION ENTERED
Wednesday, April 9, 2025APPLICATION FILING RECEIPT MAILED
Monday, September 15, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 15, 2025NON-FINAL ACTION E-MAILED
Monday, September 15, 2025NON-FINAL ACTION WRITTEN
Monday, October 13, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 13, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 14, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

pharmaessentia field printed cancer treatment namely neoplasms mpns myeloproliferative books instruction